Mimedx Group Inventory

Mimedx Group posts a inventory of $21M as of June 2026. That compares with $25M in the prior-year period — down 15.9% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Mimedx Group's inventory was $25M. The latest reading is $21M — a 15.9% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Inventory is one piece of Mimedx Group's financial statement story. At $21M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for MDXG's inventory usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Mimedx Group's other metric pages and overview cover the third.

Judging Mimedx Group against Industrials peers is usually better than using a market-wide rule of thumb. Business models inside Industrials are more comparable, which makes gaps in inventory easier to interpret. Start with $21M here, then scan peer and history charts to see if the gap is persistent.